PB2096: A PHASE 1B/2 STUDY OF GB5121, A NOVEL, HIGHLY SELECTIVE, POTENT, AND CNS-PENETRANT BTK INHIBITOR FOR RELAPSED/REFRACTORY PRIMARY/SECONDARY CNS LYMPHOMA AND PRIMARY VITREORE... by C. Soussain, C. Grommes, R. Ward, C. Peterson, M. Cravets, A. Mathias, J. Sosa, B. Kirby, Z. Ding, I. Yusuf, M. Rose, M. Steinberg, H. Tun

Get full text